Accepted for Publication: January 9, 2023.
Published Online: March 8, 2023. doi:10.1001/jamapsychiatry.2023.0059
Corresponding Author: Philip R. Corlett, PhD, Department of Psychiatry, Yale University School of Medicine, 34 Park St, New Haven, CT 06519 (philip.corlett@yale.edu).
Conflict of Interest Disclosures: Dr Corlett is cofounder and equity holder of Tetricus Labs, a startup incorporated in 2022 that attempts to diagnose and treat mental illnesses using behavioral testing and artificial neural networks. Dr Gold reported personal fees from Vera Sci outside the submitted work. No other disclosures were reported.
Funding/Support: Drs Corlett, Bansal, and Gold were supported by National Institute of Mental Health grants R01MH112887 (all), R01 MH120090 (Dr Gold), and R01 MH120089 (Dr Corlett). Dr Corlett was also supported in part by the State of Connecticut, Department of Mental Health and Addiction Services.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: This publication does not express the views of the Department of Mental Health and Addiction Services or the State of Connecticut. The views and opinions expressed are those of the authors.